China's ARM twist underlines strategic nature of tech
June 01, 2017 // By Peter Clarke, eeNews
The strategic nature of technology underlies what ARM is doing forming a joint venture company to take IP to market in China
At first glance such a move seems disadvantageous to ARM and its owner SoftBank Group (see Reports: ARM agrees to create Chinese IP firm).
ARM has spent many successful years taking its processor IP to market in China in arrangements where it, via a wholly-owned subsidiary, keeps all the monies paid in upfront payments for IP, for engineering consultancy, and for royalties on chips shipped -- presumably less some tax paid locally. After all ARM is not like some multinationals. So why would it be prepared to set up new arrangements whereby a partially owned subsidiary takes ARM-originated and locally-generated IP to market in China and only passes a proportion of the money up the line.
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
Related News
- Arm China's ex-CEO sets up RISC-V company
- Arm China selects Mentor's Questa Verification Solution to enhance power efficiency and speed development of MCU designs
- Control of Arm's China business transferred to Chinese investors
- Calculus joins tech giant ARM Holdings with investment in Bristol's Blu Wireless
- China's Xiaomi Develops First In-House Smartphone Processor in co-operation with ARM
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design